A later amendment corrects this filing, so the terms on this page may be out of date. See the latest version (2026-05-13) →
What happened
Bukwang Pharmaceutical IND disclosed an acquisition, worth US$20.4M.
For context, this deal is worth about 6.3% of the company's own total assets.
| Target | Disclosed |
|---|---|
| Deal value | US$20.4M |
| vs. company assets | 6.3% |
| Filed | 2026-04-27, Decision to acquire shares/equity in another company |
| Source | DART rcept 20260427800994 → open original filing |
Versions of this filing
- 2026-04-27Original (this page)
- 2026-05-13Amendment 1
Source: DART. Information only, not investment advice.